Abstract
Background:
Bronchopulmonary dysplasia (BPD) is a multifactor chronic lung disease that mainly affects premature infants. In this study, we investigate the preventive effects of Astragalus polysaccharides (APS) on BPD, and explore its potential molecular mechanisms.
Methods:
Lung tissues of newborn Sprague–Dawley rats from the control group, the room air plus low-dose APS group, the room air plus high-dose APS group, the BPD model group, the low-dose APS group (20 mg/kg d), and the high-dose APS group (40 mg/kg d) were examined at the 4th, 10th, and 14th d of life. The pathomorphological change was evaluated by hematoxylin–eosin staining. The content levels of superoxide dismutase (SOD) and malondialdehyde (MDA) were measured by the assay kit. Moreover, the protein and/or mRNA expression levels of NF-κBp65, CD31, ICAM-1, and TNF-α were also detected by corresponding methods.
Results:
APS decreased the inflammatory cells infiltrating compared with the BPD group. For the APS group, the activity of SOD was increased and the content of MDA was reduced compared with the BPD group at any time point. The protein and mRNA expression levels of NF-κBp65, ICAM-1, and TNF-α were all decreased, while the protein expression level of CD31 was increased in the APS-treated group, with the most significant difference of the high-dose group (P < 0.01) compared with the BPD group after birth on the 4th, 10th, and 14th d.
Conclusion:
APS can reduce airway remodeling and alveolar damage by its modulation of inflammatory mediators and antioxidation, suggesting some protective effects on BPD of neonatal rats.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Fernandez-Gonzalez A, Alex Mitsialis S, Liu X, Kourembanas S . Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012;302:L775–84.
Allen Merritt T, Deming DD, Boynton BR . The ‘new’ brochopulmonary dysplasia: challenges and commentary. Semm Fetal Neonatal Med 2009;14:345–57.
Köksal N, Kayik B, Çetinkaya M, et al. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Eur Cytokine Netw 2012;23:29–35.
Tieri P, Termanini A, Bellavista E, Salvioli S, Capri M, Franceschi C . Charting the NF-κB pathway interactome map. PLoS One 2012;7:e32678.
Speer CP . Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009;95:353–61.
Soll RF . Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia. Neonatology 2010;98:109–10.
Chu C, Qi LW, Liu EH, Li B . Radix Astragali (Astragalus): latest advancements and trends in chemistry, analysis, pharmacology and pharmacokinetics. Curr Org Chem 2010;14:1792–807
Gülbayzar S, Arica V, Hatipoğlu S, Kaya A, Arica S, Karatekin G . Malondialdehyde level in the cord blood of newborn infants. Iran J Pediatr 2011;21:313–9.
Forman HJ, Fridovich I . Superoxide dismutase: a comparison of rate constants. Arch Biochem Biophys 1973;158:396–400.
Tin W, Wiswell TE . Drug therapies in bronchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med 2009;14:383–90.
Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A . Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol (1985) 1993;74:2234–41.
Davis JM . Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr Suppl 2002;91:23–5.
Chen R, Shao H, Lin S, Zhang JJ, Xu KQ . Treatment with Astragalus membranaceus produces antioxidative effects and attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in rats. Am J Chin Med 2011;39:879–87.
Shaffer SG, O’Neill D, Bradt SK, Thibeault DW . Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat. Pediatr Res 1987;21:14–20.
Wright CJ, Kirpalani H . Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics 2011;128:111–26.
Perkins ND . Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49–62.
Gien J, Kinsella JP . Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23:305–13.
Bose CL, Dammann CE, Laughon MM . Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008;93:F455–61.
Wright CJ, Agboke F, Chen F, LA P, Yang G, Dennery PA . NO inhibits hyperoxia-induced NF-κB activation in neonatal pulmonary microvascular endothelial cells. Pediatr Res 2010;68:484–9.
Larrick JW, Wright SC . Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J 1990;4:3215–23.
He X, Shu J, Xu L, Lu C, Lu A . Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-α and IL-1β production in THP-1 cells. Molecules 2012;17:3155–64.
Yuan Y, Sun M, Li KS . Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-alpha and interleukin-8. World J Gastroenterol 2009;15:3676–80.
Hang CH, Shi JX, Li JS, Wu W, Yin HX . Concomitant upregulation of nuclear factor-κB activity, proinflammatory cytokines and ICAM-1 in the injured brain after cortical contusion trauma in a rat model. Neurol India 2005;53:312–7.
Kojima T, Sasai M, Kobayashi Y . Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Lancet 1993;342:1023–4.
Ramsay PL, O’Brian Smith E, Hegemier S, Welty SE . Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Pediatrics 1998;102(4 Pt 1):927–32.
Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ . Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995;72:F90–6.
Scherle W : A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970;26:57–60.
Robbesom AA, Versteeg EM, Veerkamp JH, et al. Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol 2003;16:1–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, XH., Jia, HL., Deng, L. et al. Astragalus polysaccharides mediated preventive effects on bronchopulmonary dysplasia in rats. Pediatr Res 76, 347–354 (2014). https://doi.org/10.1038/pr.2014.107
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2014.107
This article is cited by
-
Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1
Molecular Medicine (2020)
-
Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling
Inflammation Research (2015)
